San Diego, CA, United States of America

Kimberly Ann Teston


Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovator Spotlight: Kimberly Ann Teston**

Introduction

Kimberly Ann Teston, based in San Diego, CA, is a notable inventor known for his contributions to the field of pharmacology. With a keen focus on innovative compounds, Kimberly has developed solutions aimed at advancing medical treatments.

Latest Patents

Kimberly holds a patent for "Glucagon antagonists/inverse agonists - Non-peptide compounds comprising a central hydrazide motif and methods for the synthesis thereof." This groundbreaking work revolves around compounds that antagonize the action of the glucagon peptide hormone, presenting new avenues for therapeutic applications.

Career Highlights

Currently, Kimberly is associated with Novo Nordisk A/S, a leading company in diabetes care and hormone replacement therapy. His expertise in developing pharmacological innovations plays a significant role in the company's ongoing research and product development initiatives.

Collaborations

Throughout his career, Kimberly has collaborated with several talented individuals, including Anthony Lai Ling and Vlad Edward Gregor. Together, they contribute to advancing the understanding and capabilities within the field, further enhancing the impact of their research.

Conclusion

Kimberly Ann Teston's work exemplifies the innovative spirit within the scientific community, particularly in the development of pharmacological compounds. His contributions continue to pave the way for future advancements in medical treatments, showcasing the vital role inventors play in shaping healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…